Natural history of Polish patients with mucopolysaccharidosis type VI

Central European Journal of Medicine

Volumn 6, Issue 2, 2011, Pages 163-171

  Jurecka, Agnieszka ^a,c   Rozdzynska, Agnieszka ^a   Marucha, Jolanta ^a   Czartoryska, Barbara ^b   Wegrzyn, Grzegorz ^c   Tylki Szymanska, Anna ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

Author keywords

Anthropometric features; Growth patterns; Growth retardation; Maroteaux lamy syndrome; Mucopolysaccharidosis type VI; Physical therapy; Range of motion

Indexed keywords

ARGININE; ASPARAGINE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE; SERINE; TRYPTOPHAN;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BONE PAIN; CASE REPORT; CHILD; CORNEA DISEASE; DIARRHEA; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; FEMALE; GAIT DISORDER; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; GROWTH RETARDATION; HEARING IMPAIRMENT; HEART VENTRICLE SEPTUM DEFECT; HEPATOMEGALY; HUMAN; HURLER SYNDROME; JOINT CONTRACTURE; MALE; MAROTEAUX LAMY SYNDROME; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MOLECULAR GENETICS; PHYSIOTHERAPY; POLAND; PRIORITY JOURNAL; RANGE OF MOTION; SCHOOL CHILD; SHORT STATURE; SKELETON MALFORMATION; SLEEP APNEA SYNDROME; SLIT LAMP; SNORING; TONSILLECTOMY; UMBILICAL HERNIA; UPPER RESPIRATORY TRACT INFECTION; URINE LEVEL;

EID: 79956372928     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-010-0072-z     Document Type: Article

References (24)

1. Neufeld EF, Muenzer J., The mucopolysaccharidoses. In Scriver CR, Beaudet AL, Sly WS, et al., (Eds.), The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001
2. Azevedo AC, Schwartz IV, Kalakun L, et al., Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI, Clin. Genet., 2007, 66, 208-213
3. Hinek A, Wilson SE. Impaired elastogenesis in Hurler disease. Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly, .Am. J. Pathol., 2000, 156, 925-938 (Pubitemid 30626951)
4. Pastores GM, Meere PA. Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I), Curr. Opin. Rheum., 2005, 17, 70-78 (Pubitemid 40075651)
5. Simonaro CM, D'Angelo M, He X, et al., Mechanism of glycosaminoglycan- mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases, Am. J. Pathol., 2008, 172, 112-122 (Pubitemid 351186373)
6. Tylki-Szymanska A, Marucha J, Jurecka A, et al., Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted upper extremities range of motion in MPS I patients, J. Inherit. Metab. Dis., (in press), DOI 10.1007s/10545-010-9059-9
7. Rozdzynska A, Tylki-Szymanska A, Jurecka A, Cieslik J. Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II, Acta Paediatr., (in press), DOI 10.1111/j.1651-2227.2010.02060.x
8. Sifuentes M, Doroshow R, Hoft R, et al., A followup study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years, Mol. Genet. Metab., 2007, 90, 171-180 (Pubitemid 46108607)
9. Cardoso-Santos A, Azevedo AC, Fagondes S, et al., Mucopolisaccharidosis type VI (Maroteaux-Lamy syndrome): assessment of joint mobility and grip and pinch strength, J. Pediatr. (Rio J), 2008, 84, 130-135 (Pubitemid 351631129)
10. Tylki-Szymanska A, Rozdzynska A, Jurecka A, et al., Anthropometric data of 14 patients with mucopolysaccharidosis I: restrospective analysis and efficacy of recombinant human alpha-Liduronidase (laronidase), Mol. Genet. Metab., 2010, 99, 10-17
11. Harmatz P, Giugliani R, Schwartz I, et al., Enzyme replacement therapy formucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebocontrolled multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study, J. Pediatr., 2006, 148, 533-539
12. Scarpa M, Barone R, Fiumara A, et al., Mucopolysaccharidosis VI: the Italian experience, Eur. J. Pediatr., 2009, 168, 1203-1206
13. McGill JJ, Inwood AC, Coman DJ, et al., Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age - a sibling control study, Clin. Genet., 2010, 77, 492-498
14. Gerhardt JJ, Clinical measurements of joint motion and position in the neutral-zero method and SFTR recording: Basic principles, Disability & Rehabilitation, Volume 5, Issue 4, 1983
15. Gerhardt JJ, Rondinelli RD. Goniometric techniques for range-of-motion assessment, P h y s . Med. Rehabil. Clin. N. Am., 2001, 12, 507-527 (Pubitemid 32652538)
16. Zembaty A, Kinezyterapia, volume 1; Krakow, 2002
17. Pennock CA. A modified screening test for glycosaminoglycan excretion, J. Clin. Pathol., 1969, 22, 379-380
18. Humbel R. Rapid method for measuring arylsulfatase A and B in leucocytes as a diagnosis for sulfatidosis, mucosulfatidosis and mucopolysaccharidosis VI, Clin. Chim. Acta, 1976, 68, 339-361
19. Dubois G, Turpin JC, Bauman N., Utilisation de l'lectrophorese pour la détection de la Leucodystrophie Metachromatique á partir de leucocytes humains. C.R.Acad.Sc.Paris 278, Serie D, 1974
20. Palczewska I, Niedźwiedzka Z., Wskaźniki rozwoju somatycznego dzieci i młodziez•y warszawskiej, Medycyna Wieku Rozwojowego V. Suplement I do nr 2, 2001
21. Cieslik J, Kaczmarek M, Kaliszewska-Drozdowska MD., Dziecko Poznanskie' 90. Wzrastanie, dojrzewanie, normy i metody rozwoju. (The Poznan Child'90. Growth, Development, Reference standards.). Poznan: Wydawnictwo Naukowe Bogucki, 1994
22. Voskoboeva E, Isbrandt D, von Figura K, et al., Four novel mutatnt alleles of the arylosulfatase B gene in two patients with intermediate form of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome), Hum. Genet., 1994, 93, 259-264 (Pubitemid 24066924)
23. Karageorgos L, Brooks DA, Pollard A, et al., Mutational analysis of 105 mucopolysaccharidosis type VI patients, Hum. Mutat., 2007, 28, 897-903 (Pubitemid 47579940)
24. Piotrowska E, Jakóbkiewicz-Banecka J, Tylki-Szymanska A, et al., Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and defficiency of glycosaminoglycan synthesis, Acta Paediatr., 2009, 98, 743-749